EUVIMEDEUVIMED entdecken
Crossref

Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?

Kate Schweitzer

JAMA · 04.08.2026 · 336 (5) · 360

DOI: 10.1001/jama.2026.13149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 04.08.2026. Verfasst von Kate Schweitzer. Beteiligte Einrichtung: Associate Managing Editor, Medical News, JAMA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Medical News article discusses a request from the US Department of Health and Human Services to update testosterone therapy product labels following evolving scientific evidence of their safety.

Autor:innen und Institutionen

  • Associate Managing Editor, Medical News, JAMA.

Zitieren

APA

Schweitzer, K. (2026). Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?. JAMA, 336(5), 360. https://doi.org/10.1001/jama.2026.13149

Vancouver

Schweitzer K. Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?. JAMA. 2026;336(5):360. doi:10.1001/jama.2026.13149

BibTeX
@article{Schweitzer2026,
  author = {Schweitzer, Kate},
  title = {Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {5},
  pages = {360},
  doi = {10.1001/jama.2026.13149}
}
Kostenlos starten →